| # | Title | Journal | Year | Citations |
|---|
| 1 | Comprehensive Analysis of Hypermutation in Human Cancer | Cell | 2017 | 596 |
| 2 | Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma | Blood | 2012 | 396 |
| 3 | Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation | Biology of Blood and Marrow Transplantation | 2015 | 342 |
| 4 | Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study | Lancet Haematology,the | 2021 | 271 |
| 5 | Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis | JAMA Neurology | 2017 | 199 |
| 6 | Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR | Blood | 2019 | 199 |
| 7 | Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial | Blood | 2020 | 176 |
| 8 | Gallium and its competing roles with iron in biological systems | Biochimica Et Biophysica Acta - Molecular Cell Research | 2016 | 173 |
| 9 | A perspective on the selection of unrelated donors and cord blood units for transplantation | Blood | 2012 | 139 |
| 10 | Advances in Cancer Immunotherapy in Solid Tumors | Cancers | 2016 | 131 |
| 11 | Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies | Frontiers in Oncology | 2019 | 123 |
| 12 | Black Raspberry-Derived Anthocyanins Demethylate Tumor Suppressor Genes Through the Inhibition of DNMT1 and DNMT3B in Colon Cancer Cells | Nutrition and Cancer | 2013 | 115 |
| 13 | American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults | Blood Advances | 2020 | 113 |
| 14 | Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma | Blood | 2021 | 111 |
| 15 | National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report | Biology of Blood and Marrow Transplantation | 2015 | 105 |
| 16 | Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis | Biology of Blood and Marrow Transplantation | 2018 | 105 |
| 17 | The therapeutic potential of iron-targeting gallium compounds in human disease: From basic research to clinical application | Pharmacological Research | 2017 | 99 |
| 18 | The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017 | Haematologica | 2019 | 99 |
| 19 | The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus | Journal of Virology | 2022 | 84 |
| 20 | Black Raspberries and Their Anthocyanin and Fiber Fractions Alter the Composition and Diversity of Gut Microbiota in F-344 Rats | Nutrition and Cancer | 2017 | 82 |
| 21 | The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity | Journal of Experimental Medicine | 2021 | 82 |
| 22 | A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody–Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma | Clinical Cancer Research | 2019 | 77 |
| 23 | HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA | Journal of Hematology and Oncology | 2021 | 75 |
| 24 | Beneficial Regulation of Metabolic Profiles by Black Raspberries in Human Colorectal Cancer Patients | Cancer Prevention Research | 2015 | 73 |
| 25 | Mechanisms of thrombogenesis in polycythemia vera | Blood Reviews | 2015 | 67 |
| 26 | Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphoma | Cancer | 2016 | 67 |
| 27 | Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma | Biology of Blood and Marrow Transplantation | 2015 | 66 |
| 28 | Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy | Transplantation and Cellular Therapy | 2021 | 65 |
| 29 | CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma | Blood | 2020 | 63 |
| 30 | Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome | Neurology | 2015 | 61 |
| 31 | Improvement of survival and prospect of cure in patients with metastatic breast cancer | Breast Cancer | 2012 | 60 |
| 32 | Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors | International Journal of Cancer | 2018 | 60 |
| 33 | miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation | Laboratory Investigation | 2018 | 59 |
| 34 | All trans-retinoic acid protects against acute ischemic stroke by modulating neutrophil functions through STAT1 signaling | Journal of Neuroinflammation | 2019 | 59 |
| 35 | Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR | Cancer | 2018 | 58 |
| 36 | Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide–Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma | Biology of Blood and Marrow Transplantation | 2019 | 58 |
| 37 | Black raspberries in cancer clinical trials: Past, present and future | Journal of Berry Research | 2016 | 57 |
| 38 | Immune Checkpoint Inhibitor-Associated Type 1 Diabetes Mellitus: Case Series, Review of the Literature, and Optimal Management | Case Reports in Oncology | 2018 | 57 |
| 39 | Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma—a “real world” study | Hematological Oncology | 2017 | 56 |
| 40 | Diffuse large B‐cell lymphoma with primary treatment failure: Ultra‐high risk features and benchmarking for experimental therapies | American Journal of Hematology | 2017 | 56 |
| 41 | Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results | Nature Medicine | 2023 | 56 |
| 42 | MHC-Resident Variation Affects Risks After Unrelated Donor Hematopoietic Cell Transplantation | Science Translational Medicine | 2012 | 55 |
| 43 | Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation | Blood | 2013 | 55 |
| 44 | Universal: An Allogeneic First-in-Human Study of the Anti-Bcma ALLO-715 and the Anti-CD52 ALLO-647 in Relapsed/Refractory Multiple Myeloma | Blood | 2020 | 55 |
| 45 | Head and neck carcinoma in the United States | Cancer | 2012 | 53 |
| 46 | Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study | Lancet Haematology,the | 2020 | 53 |
| 47 | Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study | Lancet Haematology,the | 2021 | 53 |
| 48 | Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency | Nature Medicine | 2022 | 53 |
| 49 | Collagen Binding Provides a Sensitive Screen for Variant von Willebrand Disease | Clinical Chemistry | 2013 | 52 |
| 50 | The immunomodulatory potential of natural compounds in tumor-bearing mice and humans | Critical Reviews in Food Science and Nutrition | 2019 | 52 |
